# NIBP (Non-invasive Blood Pressure) Algorithm Enhancements (Characterize the Robustness of Motion Artifact Suppression)

> **NCT05185037** · — · TERMINATED · sponsor: **Philips Clinical & Medical Affairs Global** · enrollment: 17 (actual)

## Conditions studied

- Movement, Involuntary

## Interventions

- **DEVICE:** Philips IntelliVue X3 patient monitor with investigational NIBP measurement algorithm (measured once per 3 minutes)

## Key facts

- **NCT ID:** NCT05185037
- **Lead sponsor:** Philips Clinical & Medical Affairs Global
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-05-26
- **Primary completion:** 2023-11-16
- **Final completion:** 2023-11-16
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Business decision with slower than expected enrollment..
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05185037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05185037, "NIBP (Non-invasive Blood Pressure) Algorithm Enhancements (Characterize the Robustness of Motion Artifact Suppression)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05185037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*